BCD Bioscience, a Precision Prebiotic Fiber Company, Raises $12M In Series A Funding to Develop Lead Products

13 April 2022

BCD Bioscience, a biotechnology company creating precision prebiotics from natural fibers, today announced that it has completed an oversubscribed Series A financing round of $12 million led by Acre Venture Partners.

View the article

Vertical Farming startup Infarm raises $200M for international expansion

16 December 2021

Europe-based vertical farming firm Infarm this week announced a $200 million Series D. The round, led by the Qatar Investment Authority (QIA), follows last year’s $170 million raise.

View the article

Building off Pfizer investment, microbiome-focused Vedanta expands new fundraise to launch 2 studies

22nd July 2021

Vedanta wrapped up a $68 million Series D raise Wednesday morning, which included the $25 million equity investment Pfizer plunked down back in January.

View the article

Cellares, Poseida partner on cell therapy manufacturing

14th July 2021

Poseida Therapeutics has joined Cellares’ Early Access Partnership Program (EAPP) to accelerate cell therapy manufacturing.

View the article

From Printing Steaks to Raising Cash for Cultivated Beef Rollout

7th July 2021

Aleph Farms Ltd., a startup that grew meat in space and printed the world’s first slaughter-free ribeye steak, has raised more than $100 million to bring its cultivated beef to the market as soon as next year.

View the article

Aleph Farms gets $105 million investment to bring lab-grown steaks to market

7th July 2021

Funding round is led by private equity firm L Catterton and DisruptAD, the VC arm of Abu Dhabi’s holding company ADQ.

View the article

Forward Health raises $225M from investors including The Weeknd

11th March 2021

Primary care startup Forward Health is looking to expand its tech-powered, personalized healthcare model across the U.S., and will use a new $225 million Series D raise to help make it happen.

View the article

Evox Therapeutics reels in $95M to propel exosome-based pipeline

18th February 2021

The U.K.-based biotech raised £69.2 million ($95.4 million) from the likes of OrbiMed and GV to advance a pipeline of exosome-based treatments into the clinic and further develop the technology that underpins them.

View the article

Synthetic Biology Partners With AI To Delete Food Allergies

27th January 2021

Ukko recently announced a $40M Series B funding round to advance its efforts in ending food allergies for good. The funding Series was led by Leaps by Bayer—the impact investment arm of Bayer.

View the article

Cellares Adds PACT Pharma to its Early Access Partnership Program

8th January 2021

Under the partnership, PACT Pharma will provide the company with insight into autologous NeoTCR manufacturing workflows to help identify product-market fit and secure early access to the technology for an undisclosed amount

View the article

Ditch those plastic packages

26th July 2020

Six inventions for protecting our food with materials that protect the environment, too…

View the article

Evox

EVOX THERAPEUTICS ANNOUNCES A MULTI-TARGET RNA INTERFERENCE AND ANTISENSE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH LILLY

9th June 2020

Evox to use its proprietary exosome loading and CNS-targeting technologies to develop oligonucleotide drugs for the treatment of neurological disorders…

View the article

TEMASEK LEADS TROPIC BIOSCIENCES' US$28.5m SERIES B ROUND

4th June 2020

Biotech startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round led by Singapore state investment firm Temasek, bringing its total equity funding raised to US$40 million…

View the article

SIEMENS HEALTHINEERS TO EXPAND COVID-19 TESTING TO INCLUDE ANTIBODY TEST

1st May 2020

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company’s diagnostic portfolio…

View the article

MUSHROOMS WORK THEIR MAGIC AS INVESTORS SUPPORT COMPASS PATHWAYS START-UP

27th April 2020

A British start-up using the active ingredient in so-called magic mushrooms to treat clinical depression has raised $80 million from investors, including Peter Thiel, the billionaire Paypal co-founder and early Facebook investor…

View the article

Evox

EVOX THERAPEUTICS AND TAKEDA SIGN MULTI-TARGET RARE DISEASE COLLABORATION

26th March 2020

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox’s proprietary exosome technology Partnership…

View the article

FORWARD ANNOUNCES LAUNCH OF COVID-19 HOME TESTING KITS

21st March 2020

With the offering of its first at-home testing kit, Forward expands COVID-19 testing options to scale its ability to treat the growing population experiencing the barricades of an overwhelmed healthcare system…

View the article

MAGIC MUSHROOM MEDICINE PASSES FIRST CLINICAL SAFETY TRIAL

11th December 2019

Psilocybin, the main psychoactive ingredient in magic mushrooms, has taken a step towards becoming a licensed treatment for depression, with the completion of the psychedelic chemical’s first controlled clinical study.

View the article

WITH LESSONS FROM HOSPITALITY AND TECH, FORWARD EXPANDS PRIMARY CARE FOOTPRINT ON EAST COAST

22nd July 2019

The newest primary care office in the nation’s capital opened just across the street from an upscale downtown development featuring luxury condos, designer boutiques from the likes of Carolina Herrera and a Tesla showroom.

View the article